Consistently, PND-1186 impacts on oncogenic KRAS- and BRAF-stimulated MDA-MB-231 breast cancer growth and metastasis by blocking FAK and p130Cas phosphorylation [143]. The gene discussed is PTK2; the disease is breast carcinoma.